Jennison Associates’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $19.1M | Sell |
|
|||||
|
2023
Q2 | $38.7M | Buy |
|
|||||
|
2023
Q1 | $33.7M | Sell |
|
|||||
|
2022
Q4 | $32.3M | Buy |
|
|||||
|
2022
Q3 | $42.4M | Buy |
|
|||||
|
2022
Q2 | $24.2M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $16M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $50.5M | Buy |
|
|||||
|
2015
Q4 | $72.3M | Sell |
|
|||||
|
2015
Q3 | $39.2M | Sell |
|
|||||
|
2015
Q2 | $118M | Sell |
|
|||||
|
2015
Q1 | $253M | Sell |
|
|||||
|
2014
Q4 | $253M | Buy |
|
|||||
|
2014
Q3 | $219M | Sell |
|
|||||
|
2014
Q2 | $232M | Sell |
|
|||||
|
2014
Q1 | $184M | Sell |
|
|||||
|
2013
Q4 | $160M | Buy |
|
|||||
|
2013
Q3 | $126M | Buy |
|
|||||
|
2013
Q2 | $75.4M | Buy |
|